Johnson & Johnson Told To Pay $2.1bn Over Cancer-Causing Talcum Powder

Johnson & Johnson Faces Pressure To Impose A Global Ban On The Sale Of Talc Baby Powder
Johnson & Johnson Faces Pressure To Impose A Global Ban On The Sale Of Talc Baby Powder

A United States court has upheld a verdict that talcum powder sold by Johnson & Johnson caused ovarian cancer and ordered the pharmaceutical giant to pay $2.1 billion in damages.

The decision by the Missouri Court of Appeals cut by more than half the $4.4bn a jury had awarded 22 people in 2018. The court agreed that some of the plaintiffs should not have been included in the case as they were from outside the state.

But the Tuesday decision upheld the awarding of damages for the company “knowingly selling products that contained asbestos to consumers”.

“Because defendants are large, multi-billion-dollar corporations, we believe a large amount of punitive damages is necessary to have an effect in this case,” the judgement said.

“It is impossible to place a monetary value on the physical, mental and emotional anguish plaintiffs suffered because of their injury caused by defendants.”

A spokeswoman for J&J said the company would appeal the decision in the Supreme Court of Missouri, according to the Wall Street Journal.

J&J has faced thousands of lawsuits across the US alleging it failed to warn consumers of the risk of cancer from asbestos in its talc-based products.

Read Also:  NSE Opens Registration for 5th Corporate Challenge to Fight Cancer

In 2019, a California jury became the latest to award millions in damages to a plaintiff who said the company’s baby powder had given her terminal cancer.

Last month, the firm announced it was discontinuing production of its talc-based baby powder in the US and Canada, in part due to the “constant barrage of litigation advertising” over the product.

It will continue to sell the product in the rest of the world, it added.